Micro/Nano Devices for Drug Delivery and Gene Therapy

A special issue of Micromachines (ISSN 2072-666X). This special issue belongs to the section "B5: Drug Delivery System".

Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 201

Special Issue Editors


E-Mail Website
Guest Editor
Department of Mechanical Engineering, Florida Institute of Technology Melbourne, Melbourne, FL 32901, USA
Interests: biomanufacturing; organ-on-a-chip; tissue engineering; biomedical instrumentation; laser material processing

E-Mail Website
Guest Editor
Department of Biomedical Engineering, National Institute of Technology, Raipur 492010, Chhattisgarh, India
Interests: tissue engineering; biofluid; microfluidics; cognitive neuroscience

Special Issue Information

Dear Colleagues,

Micro- and nanodevices are emerging as novel drug delivery platforms due to their ability for rapid drug transport, high tissue penetration, and precision control. Research is needed on characterization and fabrication of novel nanomaterials for efficient drug delivery. Moreover, the use of novel biomaterials will allow a continuous delivery of drugs at a controlled rate for prolonged periods of time. Advances in autonomous dynamic delivery strategies based on the stimuli-responsive ability will be of interest for therapeutic applications. Micro- and nanodevices, which are also employed with surface treatment, facilitate the binding of sites for genetic materials, and they are particularly used in gene therapy. Different strategies need to be adopted to formulate nanoactuators of biological origin for the transportation of genetic materials from the surface of the cells to intracellular organelles. Fabrication of these nanoactuators by numerate routes involves a self-assembly method, chemical routes, physical treatment of bulk materials, and electrochemistry. Depending on the methodology of fabrication, the utility of the end-product for the purpose of drug and gene delivery is specified. In this Special Issue call, we are looking for potential contributions in the field of micro- and nanomachining for the development of therapeutic devices for drug and gene therapy. Contributions in the section of fabrication procedures, material aspects, and state-of-the-art applications of micro- and nanomachining architecture for gene and drug delivery are anticipated.

Prof. Dr. Kunal Mitra
Dr. Arindam Bit
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Micromachines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • actuators
  • nanotechnology
  • smart materials
  • therapeutics
  • drug delivery

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop